טוען...
Immune Thrombocytopenia (ITP): Current Limitations in Patient Management
Primary immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by isolated thrombocytopenia caused by increased platelet destruction and impaired platelet production. First-line therapies include corticosteroids, intravenous immunoglobulin, and anti-D immunoglobulin. For pati...
שמור ב:
| הוצא לאור ב: | Medicina (Kaunas) |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7761470/ https://ncbi.nlm.nih.gov/pubmed/33266286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina56120667 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|